What is the optimal first-line treatment for advanced anaplastic lymphoma kinase-rearranged non-small cell lung cancer?

ABSTRACT:

SUBMITTER: Sekine I 

PROVIDER: S-EPMC5465132 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature